Incidence of kidney cancer is on the rise, and a better understanding of molecular mechanisms involved in the cancer invasion and metastasis is required for the development of curative therapeutics.
In this study, we report that the proinflammatory cytokine prostaglandin E2 (PGE2) induces the malignant SN12C, but not benign HK2 kidney cell invasion. The PGE2 increases SN12C cell invasion through a signal pathway that encompasses EP2 and EP4, Akt, small GTPase RalA and Ral·GTP inactivator RGC2. The results support the idea that targeted interference of EP2/EP4 signal to RalA·GTP may provide benefit to patients diagnosed with advanced kidney cancer.
Written by:
Li Z, Zhang Y, Kim WJ, Daaka Y. Are you the author?
Department of Urology and Prostate Disease Center, University of Florida College of Medicine, Gainesville, FL, USA.
Reference: Oncogene. 2012 May 14. Epub ahead of print.
doi: 10.1038/onc.2012.161
PubMed Abstract
PMID: 22580611
UroToday.com Investigative Urology Section
